ArticleImmunologic research2026
Immunological spectrum in patients with thymoma: beyond good syndrome.
Article in Immunologic research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thymoma is associated with various immunological abnormalities, most notably Good syndrome; however, the full spectrum of immune dysfunction in these patients remains unclear. To evaluate the clinical and immunological characteristics of patients with thymoma and to identify occult immunodeficiency as well as associated autoimmune, infectious, and allergic conditions. In this retrospective single-center study, 37 adult patients with thymoma who had undergone thymectomy were evaluated at least one year after surgery. Clinical data, autoimmune and allergic comorbidities, infection history, and immunological parameters including immunoglobulin levels and lymphocyte subsets were analyzed. Good syndrome was identified in 2 patients (5.4%). However, additional immunological abnormalities were observed, including NK cell deficiency (16.2%), B cell lymphopenia (5.4%), isolated IgM deficiency (5.4%), and IgG subclass deficiency in 1 patient (2.7%). Recurrent infections were reported in 67.6% of patients. Autoimmune diseases were present in 86% and allergic diseases in 43.2% of patients. Patients with immunological abnormalities tended to have a higher frequency of recurrent infections. Our findings suggest that immune dysfunction in patients with thymoma may extend beyond classical Good syndrome and may involve a broader spectrum of immunological abnormalities. Systematic and long-term immunological evaluation may be important for the early detection and management of these conditions.
Indexed as
Identifiers
42390792What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.